纵向血浆代谢组学指导食管鳞状细胞癌化疗免疫治疗的动态风险评估与饮食调节
Longitudinal Plasma Metabolomics Guides Dynamic Risk Assessment and Dietary Modulation for Esophageal Squamous Cell Cancer Chemoimmunotherapy.
我们提供了首个用于ESCC精准化疗免疫治疗的代谢组学路线图,将基线预测、纵向监测和饮食调节统一为一个临床可操作的范式。
英文原题:Impact of PD-1(+)Tim-3(+)CD8(+) T cells in pretreatment tumors on chemotherapy responses in esophageal cancer.
Impact of PD-1(+)Tim-3(+)CD8(+) T cells in pretreatment tumors on chemotherapy responses in esophageal cancer.
这些结果提示,治疗前肿瘤微环境中高比例的PD-1 + Tim-3 + CD8 + TILs可能是ESCC患者NAC反应不佳的有用预测指标。
尽管化疗传统上因其对癌细胞的直接细胞毒性作用而被认识,但人们越来越关注其调节肿瘤免疫机制的能力。然而,大多数研究集中于TIL(肿瘤浸润淋巴细胞)(TILs)的定量评估,而未评估其功能状态。因此,本研究探讨了食管鳞状细胞癌(ESCC)患者治疗前TILs的耗竭状态及其对新辅助化疗(NAC)疗效的影响。从60例ESCC患者NAC前的内镜活检样本中分离出TILs。使用流式细胞术评估共表达PD-1和Tim-3的CD8 + TILs比例。通过检测耗竭标志物(TOX、LAG-3、CD39)、细胞毒性分子(颗粒酶B、穿孔素)和细胞因子(IFN-γ、TNF-α)的表达来评估其功能状态。还进行了细胞毒性试验以评估其对抗CD3scFv BALL-1细胞的直接杀伤能力。高比例的PD-1 + Tim-3 + CD8 + TILs与NAC病理反应差显著相关(p = 0.027),并在多变量分析中被确定为反应差的独立预测因子(比值比 = 4.1,95%置信区间 = 1.1-14.7,p = 0.032)。功能分析显示,PD-1 + Tim-3 + CD8 + TILs表达高水平的耗竭标志物和低水平的细胞毒性分子及细胞因子,并且表现出受损的细胞毒性功能。在反应者中,NAC后PD-1 + Tim-3 + CD8 + TILs的比例下降。这些结果表明,治疗前肿瘤微环境中高比例的PD-1 + Tim-3 + CD8 + TILs可能作为ESCC患者NAC反应差的有用预测指标。
While chemotherapy has traditionally been recognized for its direct cytotoxic effects on cancer cells, increasing attention has been directed towards its capability to modulate tumor immune mechanisms. However, the majority of studies have focused on the quantitative assessment of tumor-infiltrating lymphocytes (TILs), without evaluating their functional status. Therefore, the present study investigated the pre-therapeutic exhaustion status of TILs and its impact on the efficacy of neoadjuvant chemotherapy (NAC) in patients with esophageal squamous cell carcinoma (ESCC). TILs were isolated from 60 endoscopic biopsy samples from ESCC patients before NAC. The proportion of CD8 + TILs co-expressing PD-1 and Tim-3 was evaluated using flow cytometry. Their functional status was assessed by examining the expression of exhaustion markers (TOX, LAG-3, CD39), cytotoxic molecules (granzyme B, perforin), and cytokines (IFN-γ, TNF-α). A cytotoxic assay was also performed to evaluate their direct killing capacity against anti-CD3scFv BALL-1 cells. A high proportion of PD-1 + Tim-3 + CD8 + TILs was significantly associated with a poor pathological response to NAC (p = 0.027) and was identified as an independent predictor of poor response in multivariate analysis (odds ratio = 4.1, 95% confidence interval = 1.1-14.7, p = 0.032). A functional analysis revealed that PD-1 + Tim-3 + CD8 + TILs expressed high levels of exhaustion markers and low levels of cytotoxic molecules and cytokines and also exhibited impaired cytotoxic function. The proportion of PD-1 + Tim-3 + CD8 + TILs decreased after NAC in responders. These results suggest the potential of a high proportion of PD-1 + Tim-3 + CD8 + TILs in the pre-treatment tumor microenvironment as a useful predictor of a poor NAC response in ESCC patients.
MEMBER ACCOUNT
登录成功会直接打开下一页。